February 2015 Issue of The Ophthalmologist

Sensational headlines like “Most cancer is bad luck” aren’t helpful– so what’s the real story?

Could little balls of hydroxyapatite be the initiator of drusen formation?

The Oculentis Mplus X toric multifocal IOL has had some bad press recently – on the front page of a UK newspaper. But was it warranted?

Obstructive sleep apnea risk is associated with poor response to anti-VEGF agents

Body modification artists are offering scleral tattoos. Should they?

Who are the top 40 under 40?

Gene sequencing study identifies a gene mutation responsible for heritable cases of LCA and OMS for the first time

Tell us your thoughts and be in with a chance of winning a unique prize.

We talk with Boris Stanzel about growing retinal pigment epithelial (RPE) cells on carrier scaffolds, implanting them under the retina, and the potential it has to treat age-related macular degeneration (AMD).

Assessing the visual performance of multifocal and presbyopia-correcting IOLs far more challenging than it is with monofocal IOLs. Here’s what you need to take into account.

Fluorescent immunohistochemistry reveals the beauty of the retina.

The evolution and application of an apodized diffractive-refractive multifocal intraocular lens

What does analysis of the last five years of the cone dystrophy literature tell us about the priorities of the field and the major contributors to it?

Retinal progenitor cell transplantation offers a new approach to repairing damaged photoreceptors

Sitting Down With… Jorge Alió, Professor and Chair of Ophthalmology, Miguel Hernández University of Alicante, and founder of VISSUM Corporation.

To The New Femtosecond Laser Generation

Five Things We Learned This Month: